Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11992260 Smart probe identification for ablation modalities
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
March 30, 2021
0
Date of Patent
May 28, 2024
0
Patent Application Number
17216871
0
Patent Citations
US Patent 7416549 Multi-zone bipolar ablation probe assembly
0
US Patent 8282631 Tissue ablation with irreversible electroporation
0
US Patent 8465484 Irreversible electroporation using nanoparticles
0
US Patent 8540710 Methods and apparatuses for tissue treatment
0
US Patent 8603087 Methods and systems for treating restenosis using electroporation
0
US Patent 8647338 Method of destroying tissue cells by electroporation
0
US Patent 8801709 Endoscopic instrument for tissue identification
0
US Patent 8915911 Device and method for destruction of cancer cells
0
US Patent 8920416 Medical probe with translatable co-access cannula
0
US Patent 8926606 Integration of very short electric pulses for minimally to noninvasive electroporation
0
•••
Patent Inventor Names
Bruce R. Forsyth
0
Jonathan Tyler Gorzycki
0
Timothy A. Ostroot
0
Hong Cao
0
Larry D. Canady, Jr.
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11992260
0
Patent Primary Examiner
Linda C Dvorak
0
CPC Code
A61B 2018/00577
0
A61B 2018/00779
0
A61B 2018/00827
0
A61B 18/1206
0
A61B 2018/1467
0
G16H 40/67
0
A61B 18/1492
0
A61B 2018/00892
0
Find more entities like US Patent 11992260 Smart probe identification for ablation modalities
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE